Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
LBT Innovations Limited ( (AU:CC5) ) has shared an announcement.
Clever Culture Systems Ltd announced the impending expiry of its listed options (ASX: CC5OA) on 15 November 2025. Option holders have the choice to exercise, sell, or let their options lapse, with each option convertible into one ordinary share at an exercise price of $0.008. This announcement is crucial for stakeholders as it impacts their potential ownership and investment decisions, with the possibility of issuing 259,775,158 new shares if all options are exercised.
More about LBT Innovations Limited
Clever Culture Systems Ltd, based in Adelaide, South Australia, specializes in intelligent automation solutions for microbiology laboratories. The company has developed the Automated Plate Assessment System (APAS® Independence), an AI-driven technology for automating the imaging, analysis, and interpretation of microbiology culture plates. This technology is the only US FDA-cleared AI solution for automated culture plate reading and is distributed by Thermo Fisher Scientific, Inc to clinical customers in the US and selected European countries.
Average Trading Volume: 2,285,042
Technical Sentiment Signal: Hold
Current Market Cap: A$59.18M
See more insights into CC5 stock on TipRanks’ Stock Analysis page.